TAP Block vs Spinal Orphine for Postoperative Caesarean Section Analgetics
Comparison of Post-operative Analgetics With Transversus Abdominis Block and Spinal Morphine for Post-Caesarean Section: A Randomised Trial Study
1 other identifier
interventional
44
1 country
1
Brief Summary
The goal of this randomized controlled trial is to compare the effect of TAP block vs spinal morphine for post caesarean section analgesics. The main questions it aims to answer are:
- Which post op analgesic method works better for patients who underwent caesarean section
- The number of additional opioid needed
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2
Started Feb 2023
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 23, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 28, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 28, 2023
CompletedFirst Submitted
Initial submission to the registry
October 12, 2023
CompletedFirst Posted
Study publicly available on registry
October 18, 2023
CompletedOctober 18, 2023
October 1, 2023
2 months
October 12, 2023
October 12, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Length of time the patient needed the first additional opioid analgesics
24 hours post operative
Total need for additional opioids
24 hours post operative
Study Arms (2)
Transversus Abdominis Plane Block
EXPERIMENTALTwenty two subjects were given postoperative block administration in the transversus abdominis area on each side with ultrasonography (USG) guidance
Spinal Morphine
ACTIVE COMPARATORTwenty two subjects were given additional morphine 100 µg intrathecally
Interventions
20 cc of bupivacaine 0.2% was given to the transversus abdominis plane
Eligibility Criteria
You may qualify if:
- Indicated for caesarean section as assessed by Obstetricians
- ASA II
- Consented to be included in the study
You may not qualify if:
- Allergy history
- Spinal converted to general anesthesia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hasan Sadikin General Hospital
Bandung, West Java, 40161, Indonesia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mohammad F Maulana, MD
Faculty of Medicine Universitas Padjadjaran Bandung
- STUDY DIRECTOR
Suwarman, MD
Faculty of Medicine Universitas Padjadjaran Bandung
- STUDY DIRECTOR
Osmond M Pison, MD
Faculty of Medicine Universitas Padjadjaran Bandung
- STUDY DIRECTOR
Prapanca Nugraha, MD
Faculty of Medicine Universitas Padjadjaran Bandung
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 12, 2023
First Posted
October 18, 2023
Study Start
February 23, 2023
Primary Completion
April 28, 2023
Study Completion
April 28, 2023
Last Updated
October 18, 2023
Record last verified: 2023-10